Definition:Simple agreement for future equity (SAFE)
📄 Simple agreement for future equity (SAFE) is a financing instrument frequently used by early-stage insurtech startups to raise capital without immediately setting a fixed valuation or issuing equity, instead granting investors the right to convert their investment into shares at a future equity financing round — typically a Series A or Series B. Originated by Y Combinator in 2013, the SAFE has become a staple of startup fundraising globally and is particularly prevalent among insurance technology ventures where founders need rapid, lightweight funding to build a minimum viable product, secure initial carrier partnerships, or develop proprietary data models before the business has enough operating history to support a traditional priced round.
⚙️ A SAFE is not debt — it carries no interest rate, no maturity date, and no repayment obligation. Instead, it converts into preferred equity when a qualifying financing event occurs, at terms governed by parameters negotiated upfront: most commonly a valuation cap (the maximum post-money valuation at which the SAFE converts, protecting early investors from excessive dilution) and sometimes a discount rate (giving the SAFE holder a percentage reduction on the price per share paid by later investors). For an insurtech MGA or a claims-tech startup raising a few hundred thousand to a few million dollars in its earliest days, SAFEs offer speed and simplicity — there is no complex term sheet negotiation, no board seats at stake, and minimal legal cost compared to a priced seed round. However, because multiple SAFEs with different caps can stack up, founders must carefully model the dilutive impact that emerges when they all convert simultaneously at the next priced round.
💡 For insurance industry participants evaluating or investing in early-stage ventures — whether they are carrier innovation labs, corporate venture arms, or angel investors with insurance backgrounds — understanding SAFEs is essential. The instrument's simplicity can mask real economic consequences: a low valuation cap on a SAFE effectively sets a ceiling on the company's value from the investor's perspective, and excessive SAFE issuance before a priced round can create a "stacked cap table" that discourages institutional investors from participating later. In the insurtech world, where ventures may need extended runway to navigate licensing requirements, build actuarial credibility, and prove out loss ratios, SAFEs provide a pragmatic bridge — but both founders and investors benefit from clear modeling of conversion scenarios well before the next fundraising milestone.
Related concepts: